Researchers at Northwestern Medicine have discovered that a virus that has flown under the radar for years might be a potential contributor to the neurodegenerative disorder.

New research shows that inhibiting overactive LRRK2 enzymes could stabilize Parkinson's disease progression, with Stanford ...

The drug is Ambroxol. It’s been used for decades to treat respiratory ailments by thinning mucus and easing coughs. But now, ...

Parkinson's disease is best treated when detected early, but the cost of those tests makes that difficult. A new, 3D-printed ...

Scientists in China have identified specific physical behaviours that could provide early warning signs for Parkinson's ...

Parkinson's disease affects approximately 10 million people worldwide. It typically begins asymmetrically, initially ...

A decades-old cough medicine, Ambroxol, could be on the verge of a dramatic second act—not for sore throats, but for ...

Ambroxol, a cough medication, may help stabilize the neuropsychiatric symptoms of Parkinson's disease dementia, a new study ...

A study links living near golf courses to higher Parkinson's risk, with strongest association found in those one to three ...

The results of experiments in mice models were "astounding," said biochemist Suzanne Pfeffer of Stanford University.

These findings highlight the significance of rearing behavior and behavioral lateralization as potential behavioral markers ...

A breakthrough brain scan shows Parkinson’s drugs can misfire in the brain, helping some patients less than others. The fix?